(firstQuint)Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen.

 PROTOCOL OUTLINE: This is a randomized, multicenter study.

 Patients are randomized to receive intravenous acetylcysteine or placebo for 72 hours.

 Treatment must begin within 12 hours of hospitalization.

 Patients who advance to grade III or IV encephalopathy are eligible for liver transplantation.

 Patients are followed at 3 weeks.

.

 Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen@highlight

OBJECTIVES: I.

 Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.

